Dukoral Market Report 2026

Dukoral Market Overview

• The Dukoral market growth in the historic period has been driven by cholera outbreaks in endemic regions, rising international travel flows • Market expansion is supported by increasing global travel activity, climate change driven spread of cholera • Growth Driver: Rising Cholera Incidence Fuels Demand For Vaccine • Market Trend: Advancements In Low-Cost Oral Cholera Vaccines • Asia-Pacific was the largest region in 2025.

What Is Covered Under Dukoral Market?

Dukoral is an oral vaccine that prevents cholera and certain types of diarrhea caused by the enterotoxigenic Escherichia coli (ETEC) bacteria. The vaccine contains inactivated cholera toxin and a recombinant cholera toxin B subunit, which stimulate the body to produce an immune response. It is typically recommended for travelers to areas with a high cholera or ETEC infection risk. The main types of indications for dukoral are cholera and traveler's diarrhea. Cholera, a severe bacterial infection caused by Vibrio cholerae and spread through contaminated water or food, leads to acute diarrhea and dehydration, and the Dukoral vaccine provides protection by stimulating the immune system to fight the bacteria before infection occurs. The distribution channels include pharmacies; travel clinics; healthcare providers for end users, such as hospitals; clinics; ambulatory care; and home care.

What Is The Dukoral Market Growth Forecast?

The growth in the forecast period can be attributed to increasing global travel activity, climate change driven spread of cholera, higher preventive healthcare spending, advancements in oral vaccine formulations, stronger focus on traveler health safety. Major trends in the forecast period include oral vaccine adoption expansion, growth in travel health immunization, rising focus on enteric disease prevention, preference for non injectable vaccines, increasing awareness of cholera and etec risks.

What Is The Driver Of The Dukoral Market?

The rising incidence of cholera cases is expected to drive the growth of the dukoral market. Cholera, an acute diarrheal disease caused by the ingestion of food or water contaminated with Vibrio cholerae, leads to severe dehydration and, in extreme cases, death. Cholera's rise is fueled by poor sanitation, contaminated water, and climate change, which together create ideal conditions for outbreaks. Dukoral, an oral cholera vaccine, helps decrease cholera cases by stimulating immunity against Vibrio cholerae bacteria and its toxin, reducing infection risk. For instance, in September 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, in 2023, cholera cases increased by 13%, with a significant 71% surge in fatalities compared to 2022, resulting in over 4,000 deaths from a preventable and easily treatable disease. Therefore, the rising incidence of cholera cases is projected to fuel the growth of the dukoral industry.

Key Players In The Global Dukoral Market

Major companies operating in the dukoral market are Valneva SE

Global Dukoral Market Trends and Insights

Major companies operating in the dukoral market are focusing on innovation in vaccine formulations, such as low-cost oral cholera vaccines, to enhance vaccine efficacy and simplify administration. Low-cost oral cholera vaccines are affordable vaccines designed to prevent cholera, offering easier administration and accessibility, particularly in resource-limited regions. Low-cost oral cholera vaccines refers to affordable, easy-to-administer vaccines taken by mouth that are designed to protect against cholera, particularly in low-resource and outbreak-prone regions. For instance, in April 2023, the International Vaccine Institute (IVI), a South Korea-based non-profit, autonomous international organization, partnered with the University of Gothenburg, a Sweden-based institution, to develop DuoChol, a low-cost oral cholera vaccine (OCV). This collaboration aims to advance the development of DuoChol, which features a dry formulation of inactivated bacterial whole cells and cholera toxin B subunit in capsule form. It has a similar composition to DUKORAL but offers improved thermostability, stability at higher temperatures, and reduced weight and volume. The Phase I clinical trial will take place in Sweden, funded by the Wellcome Trust and the Swedish government.

What Are Latest Mergers And Acquisitions In The Dukoral Market?

In July 2023, NorthX Biologics, a Sweden-based biotechnology company specializing in biologics manufacturing and process development, acquired a manufacturing unit from Valneva SE for an undisclosed amount. With this acquisition, NorthX Biologics aims to enhance its capabilities in producing advanced biologics and support the development of innovative therapies, positioning itself as a leader in the Nordic biopharmaceutical landscape. Valneva SE is a France-based biotech company that develops and commercializes vaccines, including Dukoral, an oral vaccine.

What Defines the Dukoral Market?

The dukoral market consists of sales of vaccine kits, oral liquid formulations, and oral capsule formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Dukoral Market Report 2026?

The dukoral market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the dukoral industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.